Gastric mucosal phospholipids and gastroduodenal diseases.
نویسندگان
چکیده
منابع مشابه
Gastroduodenal mucosal alkaline secretion and mucosal protection.
The gastroduodenal mucosa is a dynamic barrier restricting entry of gastric acid and other potentially hostile luminal contents. Mucosal HCO3(-) is a key element in preventing epithelial damage, and knowledge about HCO3(-) transport processes, including the role of the cystic fibrosis transmembrane conductance regulator channel, and their neurohumoral control are in rapid progress.
متن کاملPeptic activity and gastroduodenal mucosal damage.
This contribution reviews briefly the history of the discovery and characterization of peptic activity; secretory models and current concepts regarding the regulation of pepsinogen secretion; and evidence that pepsin is a necessary co-factor for gastroduodenal mucosal injury. Several animal studies indicate that peptic activity is required for acid- and nonsteroidal anti-inflammatory drug-induc...
متن کاملGastric microflora in gastroduodenal disease.
Gastric juice cultures were positive in all patients with gastric disorders and 44% with duodenal ulcers. A positive correlation was observed between pH and positivity of gastric cultures (JPMA 32:282, 1982).
متن کاملGASTRIC MUCOSAL PROTECTION Peripheral mechanisms of gastric mucosal protection: mediators, receptors Gastric mucosal barrier to acid
Gastric mucosal integrity can be influenced both by peripheral and central mechanisms. In the last decades the peripheral mechanisms of gastric mucosal defense have been intensively studied, and many details have been clarified. Some of these results have served as a basis for the development of new strategies, therapeutic targets in the treatment of gastric mucosal lesions. On the other hand, ...
متن کاملGastroduodenal Mucosal Injury in Patients Taking Low-Dose Aspirin and the Role of Gastric Mucoprotective Drugs: Possible Effect of Rebamipide
The present study was conducted to investigate the prevalence of mucosal injury in patients taking low-dose aspirin in Japan and examine the effect of gastric mucoprotective drugs on aspirin-related gastroduodenal toxicity. We selected 530 patients who had taken low-dose aspirin for 1 month or more after undergoing esophagogastroduodenoscopy from 2005 through 2006 at Teikyo University Hospital,...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Gut
سال: 1993
ISSN: 0017-5749
DOI: 10.1136/gut.34.12.1741-c